|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/10 | |
| A61K 47/32 | |||
| A61K 9/51 | |||
| A61P 15/00 |
| (11) | Patento numeris | 2844227 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13723350.8 |
| Europos patento paraiškos padavimo data | 2013-05-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-03-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-11-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/039499 |
| Data | 2013-05-03 |
| (87) | Numeris | WO 2013/166408 |
| Data | 2013-11-07 |
| (30) | Numeris | Data | Šalis |
| 201261642261 P | 2012-05-03 | US |
| (72) |
POPOV, Alexey, US
|
| (73) |
Kala Pharmaceuticals, Inc.,
490 Arsenal Way, Suite 120, Watertown, MA 02472,
US
|
| (54) | PHARMACEUTICAL NANOPARTICLES SHOWING IMPROVED MUCOSAL TRANSPORT |
| PHARMACEUTICAL NANOPARTICLES SHOWING IMPROVED MUCOSAL TRANSPORT |